Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in gastric bypass surgery (PATRY)
NCT05464394Phase 3Unknown
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- Sep 2022
- Primary completion
- Sep 2024
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in hemorrhage comparing Tranexamic acid Arm with Placebo Arm (2 arms). Primary endpoint: Postoperative re-intervention rate at 30 days. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT05464394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05464394.